Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double-Blind, Placebo-Controlled Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease

NCT01305824 is registered in ClinicalTrials.gov with Proteon Therapeutics as lead sponsor.

NCT NCT01305824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01305824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double-Blind, Placebo-Controlled Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Lead sponsor
Proteon Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2011
Completion date
November 30, 2012
Enrollment
151 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease